OAM
TEVA icon

Oxford Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Oxford Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,000
Closed -$650K – 447
2024
Q2 		$650K Sell
40,000
-24,000
-38% -$370K 0.63% 38
2024
Q1 		$903K Buy
+64,000
New +$807K 0.94% 16
2020
Q1 		$106K Sell
11,829
-455,267
-97% -$4.66M 0.01% 141
2019
Q4 		$4.58M Sell
467,096
-280,537
-38% -$2.5M 0.13% 174
2019
Q3 		$5.14M Buy
+747,633
New +$5.73M 0.12% 195
2019
Q1 		– Sell
-185,841
Closed -$2.87M – 1967
2018
Q4 		$2.87M Sell
185,841
-81,912
-31% -$1.68M 0.07% 311
2018
Q3 		$5.75M Buy
267,753
+88,636
+49% +$2.06M 0.12% 190
2018
Q2 		$4.41M Sell
179,117
-107,078
-37% -$2.18M 0.08% 253
2018
Q1 		$4.89M Buy
+286,195
New +$5.59M 0.1% 198
2016
Q4 		– Sell
-224,434
Closed -$10.3M – 863
2016
Q3 		$10.3M Buy
224,434
+123,986
+123% +$6.47M 0.32% 66
2016
Q2 		$5.05M Sell
100,448
-28,720
-22% -$1.53M 0.17% 147
2016
Q1 		$6.91M Sell
129,168
-42,003
-25% -$2.46M 0.2% 113
2015
Q4 		$11.3M Buy
171,171
+132,187
+339% +$8.17M 0.27% 65
2015
Q3 		$2.2M Buy
38,984
+29,511
+312% +$1.91M 0.07% 272
2015
Q2 		$560K Sell
9,473
-20,543
-68% -$1.27M 0.02% 514
2015
Q1 		$1.87M Sell
30,016
-30,134
-50% -$1.75M 0.05% 376
2014
Q4 		$3.43M Buy
+60,150
New +$3.35M 0.08% 262
2014
Q3 		– Sell
-94,567
Closed -$4.96M – 755
2014
Q2 		$4.96M Buy
+94,567
New +$4.83M 0.16% 167
2014
Q1 		– Sell
-241,115
Closed -$9.66M – 765
2013
Q4 		$9.66M Buy
+241,115
New +$9.49M 0.24% 107
2013
Q3 		– Sell
-229,360
Closed -$8.99M – 895
2013
Q2 		$8.99M Buy
+229,360
New +$8.93M 0.24% 102

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Oxford Asset Management's TEVA Position: Q3 2024 in Review

Oxford Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 40,000 shares — an estimated $650K sold.

Oxford Asset Management first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $11.3M in Q4 2015. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Oxford Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Oxford Asset Management sold 40,000 Teva Pharmaceuticals shares in Q3 2024, an estimated $650K.
  • Oxford Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Oxford Asset Management's Teva Pharmaceuticals position peaked at $11.3M in Q4 2015.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Oxford Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.